Three Mount Sinai Researchers Elected to National Academy of Medicine

Three faculty members from the Icahn School of Medicine at Mount Sinai have been elected to the National Academy of Medicine (NAM).  Election to the NAM is considered one of the highest honors in health and medicine, recognizing individuals who have demonstrated outstanding professional achievement and commitment to service.  The Icahn School of Medicine faculty members who were elected this year are:

“These newly elected members represent the most exceptional researchers and leaders in science, health, and medicine,” says Dennis S. Charney, MD, the Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai.  “The election of Drs. Calman, Hurd, and Parsons is a distinguished achievement and well-deserved recognition of each of their leadership efforts and significant contributions to their particular fields of study.”

Neil S. Calman, MD, MMS

Dr. Calman is a nationally recognized leader in the field of family medicine and co-founder of the Institute for Family Health, a network of 31 federally qualified community health centers providing access to high-quality, fully integrated primary health care, behavioral health services, and oral health care targeted to the needs of medically underserved communities.  In 2012, through an affiliation between the Institute and Mount Sinai, Dr. Calman became Professor and Chair of the new Department of Family Medicine and Community Health at the Icahn School of Medicine at Mount Sinai, where family physicians now practice and teach with full clinical privileges in the Mount Sinai Health System and its seven affiliated hospitals.  Since 1983, Dr. Calman has led the Institute in developing family health centers in the Bronx, Manhattan, Brooklyn, and the Hudson Valley as well as three community-based family medicine residency training programs now part of Mount Sinai’s graduate medical education consortium.  Dr. Calman is a leader in the national effort to eliminate racial and ethnic disparities in health outcomes, leading to the Institute’s designation by the Centers for Disease Control and Prevention (CDC) as a National Center of Excellence in the Elimination of Disparities. This work has been supported by funding from the CDC, the National Institutes of Health, and the Health and Human Services Office of Minority Health, as well as the New York State and New York City health departments.

Yasmin L. Hurd, PhD

Dr. Hurd is a recognized expert in translational neuroscience and addictive disorders.  Her multidisciplinary research investigates the neurobiology underlying addiction disorders and related psychiatric illnesses.  Dr. Hurd has been a leader in the field through her translational approaches to examine molecular and neurochemical events in the human brain and animal models to ascertain neurobiological correlates of behavior. She conducted pioneering studies of gene expression and epigenetic modifications in the postmortem human brain, research that has provided significant molecular insights about neuropsychiatric disorders. Already at early stages of her career, she helped to develop the in vivo microdialysis technique that enabled extracellular concentrations of neurotransmitters to be measured in live, active animals and is now used in many fields. Dr. Hurd has been a leading researcher regarding the developmental effects of cannabis and her innovative studies revealing cross-generational effects of cannabis have had broad implications. Her basic science research is complemented by human clinical studies with significant focus on the development of novel therapies.  She is frequently published, serves on many national scientific boards, and has been a prominent scientific voice to the public regarding addiction and its health impact.

Ramon E. Parsons, MD, PhD

Dr. Parsons is a highly acclaimed researcher in cancer genetics who brings an interdisciplinary, holistic approach to The Tisch Cancer Institute. His research goals include identifying the genetic and biochemical changes that lead normal cells to develop into aggressive cancer cells. He discovered a tumor suppressor gene often mutated in cancer called PTEN, which provided a critical therapeutic target in a variety of cancers including breast, brain, prostate, and endometrial cancers. He favors organ-based studies that rely on human tissues, which he feels are essential to understanding the biochemistry of disease.  The author of more than 90 original peer-reviewed articles, Dr. Parsons also has served as an editor on several journals, including Cancer Research.

New members are elected by current, active members through a selective process that recognizes people who have made major contributions to the advancement of the medical sciences, health care, and public health. Established in 1970 by the National Academy of Sciences, NAM is a national resource that provides independent, objective analysis and advice on health issues.

The new NAM members bring Mount Sinai’s total membership in the prestigious group to 24 present and past faculty members.  The distinguished Mount Sinai faculty members whom Drs. Calman, Hurd and Parsons join in earning this honor are: • Joseph D. Buxbaum, PhD • Dennis S. Charney, MD • Kenneth L. Davis, MD • Robert J. Desnick, MD, PhD • Kurt W. Deuschle, MD •Angela Diaz, MD, MPH • Valentin Fuster, MD, PhD • Bruce Gelb, MD • Alison M. Goate, DPhil • E. Cuyler Hammond, DSc • Kurt Hirschhorn, MD • Philip J. Landrigan, MD, MSc • Diane E. Meier, MD • Eric J. Nestler, MD, PhD • Maria Iandolo New, MD • Peter Palese, PhD • Lynn D. Richardson, MD • Hugh A. Sampson, MD • Irving J. Selikoff, MD • Pamela Sklar, MD, PhD • Barbara G. Vickrey, MD, MPH.

Read the press release

Women’s Cancer Program Is an Oasis of Expert Care

Stephanie V. Blank, MD, at Mount Sinai Chelsea

Patients with gynecologic and breast cancers are finding advanced care and a peaceful oasis at the Women’s Cancer Program at Mount Sinai Chelsea, a clinical practice—located in the iconic Google building on 15th Street between 8th and 9th avenues—that was years in the making.

“The Women’s Cancer Program is unique in many ways,” says Luis M. Isola, MD, Gerald J. Friedman Chair in Oncology, and Director, Cancer Clinical Programs, Mount Sinai Health System. “In its location in New York, there are essentially no other cancer centers,” he says, referring to the west side of Manhattan south of 34th Street. “And certainly none affiliated with a major academic institution like the Icahn School of Medicine at Mount Sinai.”

The Program is based at Mount Sinai Chelsea, an 80,000-square-foot site with pastel walls, comfortable seating, and artfully placed flowers and paintings. “It has a very zen, serene atmosphere,” Dr. Isola says. “On any given day, hundreds of patients go in and out of the center, but there is no noise, there are no lines or bottlenecks. It’s efficient, and for patients, it’s a very welcoming environment.”

The Program provides “one-stop” care for patients diagnosed with breast or gynecologic cancer, says Stephanie V. Blank, MD, Director of Women’s Health, Mount Sinai Chelsea, and Professor of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai.

The practice emphasizes a team approach, she says, with the team composed of a gynecologic oncologist, a nurse practitioner, an infusion nurse, a genetic counselor, a nutritionist, a social worker, a psychiatrist, and a financial counselor, among others.

Breast surgeon Sarah P. Cate, MD, Assistant Professor of Surgery, Icahn School of Medicine at Mount Sinai, with patient Abigail George at Mount Sinai Chelsea.

The Program also strives to see any patient newly diagnosed with cancer within 24 hours. “We’ll get them right in,” Dr. Blank says. “Our goal is to provide the most excellent patient-centered care and make the whole experience as easy and pleasant as possible for women and their families going through a trying time.”

Dr. Blank, a renowned physician-scientist, says the Program delivers advanced treatments by taking part in several clinical trials, including combination immunotherapy for “frontline” patients—those just diagnosed with cancer. Another trial, for recurrent ovarian cancer, delivers drugs with conjugated antibodies, which are designed to target and kill cancer cells and spare healthy cells. The Program is also inaugurating a sexual health clinic focused on cancer survivors and an onco-fertility clinic dealing with the reproductive challenges faced by women with cancer.

The gynecologic oncology practice works closely with the breast cancer practice, which provides similarly comprehensive care. “We have breast imaging and ambulatory surgery. Except for radical mastectomy with major surgery, all diagnostic and surgical treatment can be done here,” Dr. Isola says. “We have three excellent oncologists who exclusively treat breast cancer, and we have access to supportive oncology, including palliative care, nutritional counseling, and a psychiatrist who is very helpful with emotional support.”

In addition to the Women’s Cancer Program, Mount Sinai Chelsea offers a range of other services for both men and women, including a skin cancer program, hematology-oncology, ambulatory surgery, radiology, and an infusion center that treats patients with cancer and nonmalignant conditions. New spaces for phlebotomy and dermatology, and a lounge for patients, are expected to be completed in coming months.

The Mount Sinai Health System has long been planning for a “future of medicine” that includes improving access and increasing the quality of care for people south of 34th Street, close to where they live and work. “We made a very explicit decision to grow with this practice in Chelsea,” Dr. Isola says. “Here we are, a few years later, and it’s becoming a reality.”

White Coat Ceremony Starts a Journey for Students

The Class of 2021, including Benjamin Adegbite, left, and Daniel Afonin, center, read an oath expressing their ideals.

In a symbolic celebration that marked the beginning of their medical education, 140 first-year students at the Icahn School of Medicine at Mount Sinai gathered on Monday, September 18, for the 20th Annual White Coat Ceremony. Family and friends cheered the Class of 2021 as the students walked to the stage of Stern Auditorium to be draped in white coats by faculty; they received their first stethoscopes just after the jubilant event.

“I know you have it in you to become the leaders of our profession and the world at large,” Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs, Mount Sinai Health System, told the class in his welcoming address. “You come to Mount Sinai from top undergraduate colleges and universities and have mean GPA and MCAT scores as high as any other students in the nation. But you are much more than that. It is not the academic accolades that convince me you have it in you to change the world. It is the fire in your eyes I see today that lets me know we are in capable hands.”

The incoming students—whose ages range from 21 to 36—represent diverse backgrounds and experiences. Nineteen percent identify as underrepresented minorities, and 50 percent are women. The class includes a Marine, a rabbi, a pastor, an ultramarathon runner, a sailor who has traveled one-third of the way around the world, and a student who grew up in Carver Houses, the public housing project across the street from The Mount Sinai Hospital. Dr. Charney said of that student, “It was a short walk across the street, but a long road to get here. She is an inspiration.”

Keynote speaker Paul R.G. Cunningham, MD

Valerie Parkas, MD, Senior Associate Dean for Recruitment and Admissions, Icahn School of Medicine at Mount Sinai, administered an oath written by the students that expressed their ideals. The class pledged “to understand our patients’ diverse backgrounds and identities and treat them as partners in their care” and “to build upon the pillars of medicine through evidence-based practices and innovation.”

The keynote speaker was Paul R.G. Cunningham, MD, President of the North Carolina Medical Society, and Dean Emeritus of the Brody School of Medicine at East Carolina University in Greenville, North Carolina. Dr. Cunningham outlined his long career as a surgeon and educator, and he fondly recalled his residency at Mount Sinai, where he was mentored by Arthur H. Aufses Jr., MD, retired Chair of the Department of Surgery, whom he called his “professional father” and a “surgeon’s surgeon.” In their own professional journey, Dr. Cunningham advised the class to focus on outdoing themselves instead of merely competing with others, and to keep sight of their “why”—the vision that led them to study medicine.

Dr. Charney urged the Class of 2021 to “dream big.” And he posed challenges for the years ahead: translating the breakthroughs in DNA sequencing and precision medicine into clinical care; finding treatments for mental illness, substance abuse, and Alzheimer’s disease; and finding ways to treat, and even cure, the most common cancers.

“It is to your generation that we now turn, to guide us toward a new age of insight and discovery,” Dr. Charney said. “And it is our job, as your teachers, to guide you.”

Manjil Chatterji, MD, Assistant Professor of Radiology, and Medical Education, Icahn School of Medicine at Mount Sinai, bestowed a white coat on Courtney Connolly.

Nurses Salute Physician Colleagues for Excellence

From left: James F. Holland, MD; Hanna Irie, MD, PhD; Donna Berizzi, RN, MSN, presenter of the Team Recognition Award; Amy Tiersten, MD; Julie Fasano, MD; Aarti Sonia Bhardwaj, MD; and Frances Cartwright, PhD, RN-BC. Not pictured is Charles L. Shapiro, MD.

Before a celebratory audience of faculty and staff, and family and friends, nine physicians at The Mount Sinai Hospital were honored by nurse colleagues and Nursing leadership with the 30th Annual Physician of the Year Award. The ceremony, held Tuesday, September 26, at Hatch Auditorium, is a yearly salute to physicians who excel in patient care—and more—and take leadership roles in creating strong collaborative partnerships with nurses.

“There is nothing more validating for a clinical physician than to have the respect and admiration of your colleagues in nursing,” said David Reich, MD, President and Chief Operating Officer, The Mount Sinai Hospital.

Presentations included heartfelt and sometimes humorous recollections from nursing colleagues that spotlighted extraordinary examples of kindness, outstanding patient care, leadership, collegiality, and respect. For only the second time, a Team Recognition Award was presented—to the medical oncology attendings at the Dubin Breast Center of The Tisch Cancer Institute.

The team includes legendary oncologist James F. Holland, MD, the Distinguished Professor of Neoplastic Diseases, and Professor of Medicine (Hematology/Medical Oncology), and Oncological Sciences, who is considered one of the founding fathers of cancer chemotherapy.

Umesh K. Gidwani, MD

Laura K. Stein, MD

Throughout the ceremony, recipients emotionally detailed the familial bonds developed between physicians and nursing. “I have learned so much about what it means to take care of patients but also what it means to take care of your colleagues and friends,” said Laura K. Stein, MD, Department of Neurology, recipient of the Fellow Award.

Added Frances Cartwright, PhD, RNBC, Edgar M. Cullman, Sr. Chair of the Department of Nursing, and Chief Nursing Officer and Senior Vice President for Patient  Care Services, The Mount Sinai Hospital: “A growing body of evidence shows that when physicians and nurses have a trusting, open, and collaborative relationship, we have improved patient safety and quality of patient experience.”

 

The 2017 honorees were:

Team Recognition Award: Medical Oncology team, the Dubin Breast Center of The Tisch Cancer Institute

Aarti Sonia Bhardwaj, MD

Julie Fasano, MD

James F. Holland, MD

Hanna Irie, MD, PhD

Charles L. Shapiro, MD

Amy Tiersten, MD

Attending Award: Umesh K. Gidwani, MD, Associate Professor, Medicine (Pulmonary, Critical Care and Sleep Medicine)

Fellow Award: Laura K. Stein, MD, Department of Neurology

House Officer Award: Jeffrey D. Nusbaum, MD,PGY-4S, Department of Emergency Medicine.

 

 

Mount Sinai Medical Volunteers Halfway Through Puerto Rico Mission

Mount Sinai’s medical volunteers (named below) in Fajardo, Puerto Rico.

In often steamy conditions amid heavy rains, 10 medical volunteers from the Mount Sinai Health System are attending to almost 200 patients a day in Fajardo, Puerto Rico. Halfway through their two-week mission to the island still recovering from Hurricane Maria, the contingent of three physicians and seven nurses have treated common injuries and illnesses, minor trauma, infections, and complications that Puerto Rico residents have experienced because their access to medication to treat chronic illnesses was disrupted by the storm. The team coordinates the care of more critically ill patients with the local hospital, which is operating on generator power.

 

Hospital HIMA San Pablo - Fajardo

An exterior view of the volunteer housing tent

Volunteers enjoy some down time

From left: Melanie Pratts, RN, and Erin Hogan, RN

After 12-hour shifts, volunteers eat prepackaged meals, launder clothing in a sink, and bed down on cots in a tent. Though the days are long and conditions difficult, the team is thoroughly committed to assisting the people of Puerto Rico.

The Mount Sinai volunteers are working as part of a larger team that includes a federal Disaster Medical Assistance Team, the Department of Defense, and volunteers from Montefiore Medical Center. This important mission is coordinated through the Puerto Rico Department of Health, U.S. Department of Health and Human Services, and the New York State Department of Health. As this two-week mission comes to a close, preparations are under way to send an additional team from Mount Sinai.

 

 

Back row from left: Colleen Fischer, RN, Nurse Manager, Mount Sinai Beth Israel; Karendip Kaur Braich, MD, Nephrology Fellow, Icahn School of Medicine at Mount Sinai; Helen Rosario, RN, Mount Sinai Brooklyn; and Emma Kaplan-Lewis, MD, Assistant Professor, Medicine, Infectious Diseases, Icahn School of Medicine at Mount Sinai.

Front row from left: Juan Baez, RN, Mount Sinai St. Luke’s; Melanie Pratts, RN, Director of Medical Systems, New York Eye and Ear Infirmary of Mount Sinai; Christine Mahoney, RN, MS, AGACNP-BC, CCRN, Senior Vice President, Patient Care Services and Chief Nursing Officer, Mount Sinai Downtown; Stacey A. Conklin, MS, MSN, RN, NE-BC, Vice President for Patient Care Services, New York Eye and Ear Infirmary of Mount Sinai; and Kevin Munjal, MD, Assistant Professor, Emergency Medicine, Icahn School of Medicine at Mount Sinai.

 

 

A Health Care Transformation South of 34th Street

Mount Sinai leaders, including Jeremy Boal, MD, President, Mount Sinai Downtown, front row, second from left, and Kelly Cassano, DO, Chief of Ambulatory Care, Mount Sinai Downtown, with scissors, celebrated the opening of the new Urgent Care facility at Union Square with local politicians and community organizers. They included Claude L. Winfield, Vice Chair, Manhattan Community Board 6; New York State Assembly Member Richard N. Gottfried, District 75; Wally Rubin, District Manager, Manhattan Community Board 5; and Scott Hobbs, Deputy Director, and William D. Abramson, Co-Chair, of the Union Square Partnership.

Several doors down from the Union Square subway station sits one of the Mount Sinai Health System’s hidden gems—a 350,000-square foot, full-service ambulatory center that includes physician offices for more than 30 clinical care specialties—and a new Urgent Care facility for adults and children. The recently renovated ambulatory center and the new Urgent Care center are part of Mount Sinai’s plan to transform health care services for New Yorkers south of 34th Street.

Deceptively simple from the outside, the ambulatory center’s sleek glass and stone entry gives way to five busy floors where more than 350 physicians and 550 staff take care of patients who live and work in downtown Manhattan, Brooklyn, and surrounding areas. The Mount Sinai Union Square ambulatory center includes an outpatient facility with six operating rooms, a 17-chair chemotherapy infusion suite, doctor’s offices, exam rooms, radiological suites with the latest technology, space for in-office procedures, and a pharmacy.

An indoor parking garage on the lower level conveniently leads directly into the building. At the beginning of 2018, Mount Sinai Union Square will open new Cardiology and Respiratory institutes, followed by new OB-GYN, general Pediatric, and specialty Pediatric suites later in the year.

At the new Urgent Care facility, adults and children receive the highest quality care from board-certified emergency medicine physicians who treat patients seven days a week and during evening hours. The facility also includes a full X-ray room and point-of-care testing that can provide patients with the answers they need immediately. For medical emergencies, patients south of 34th Street will continue to be seen at Mount Sinai Beth Israel’s (MSBI) Emergency Department, which will be in operation until the new Mount Sinai Beth Israel hospital opens.

“Mount Sinai is leading the way in improving the health care experience for people who live and work in this community,” says Jeremy Boal, MD, President, Mount Sinai Downtown, Executive Vice President and Chief Clinical Officer, Mount Sinai Health System. “Health care delivery is changing and we are committed to embracing this change with excellent and convenient care that keeps people healthy. Our significant investment in modernization attests to our commitment to the community south of 34th Street, where we intend to stay and grow.”

Within the next couple of years construction will begin on the new MSBI, resulting in a technologically sophisticated hospital that conforms to the demands of modern, twenty-first century medicine. This hospital of the future at MSBI will incorporate the rapidly changing improvements taking place in the field of medicine in a new infrastructure that requires a smaller physical footprint. It will be located next door to an enhanced New York Eye and Ear Infirmary of Mount Sinai.

“Our ambulatory services were designed to address the community’s needs for high-quality specialized care under one roof,” says Kelly Cassano, DO, Chief of Ambulatory Care, Mount Sinai Downtown. “Patients who visit the Mount Sinai Union Square building will receive full-service urgent care services or the comprehensive specialized services they require.”

Indeed, as Paul Zucker, Vice President of Ambulatory Operations, points out, the Union Square facility houses two MRI machines—including one that is brand new—along with mammography and radiation oncology equipment, and an infrastructure that handles wide-ranging specialties that include maternal fetal medicine and vascular surgery. “What differentiates us,” he says, “is that patients can access virtually every medical specialty without ever leaving the building.”

Pin It on Pinterest